The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.

Jessica E. Stine; Hui Guo; Hui Guo; Xiugui Sheng; Xiaoyun Han; Xiaoyun Han; Monica N. Schointuch; Timothy P. Gilliam; Paola A. Gehrig; Chunxiao Zhou; Victoria L. Bae-Jump

doi:10.18632/ONCOTARGET.5834

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.

Jessica E. Stine
, Hui Guo
, Hui Guo
, Xiugui Sheng
, Xiaoyun Han
, Xiaoyun Han
, Monica N. Schointuch
, Timothy P. Gilliam
, Paola A. Gehrig
, Chunxiao Zhou
, Victoria L. Bae-Jump

University of North Carolina at Chapel Hill
Jinan University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Oncotarget
Volume	7
Issue number	1
DOIs	https://doi.org/10.18632/ONCOTARGET.5834
State	Published - Jan 5 2016
Externally published	Yes

Disciplines

Pharmacology
Medicine and Health Sciences

Access to Document

10.18632/ONCOTARGET.5834License: Unspecified

Cite this

@article{dc18cbe4ff7440ed8d5146b5251ef271,

title = "The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.",

author = "Stine, \{Jessica E.\} and Hui Guo and Hui Guo and Xiugui Sheng and Xiaoyun Han and Xiaoyun Han and Schointuch, \{Monica N.\} and Gilliam, \{Timothy P.\} and Gehrig, \{Paola A.\} and Chunxiao Zhou and Bae-Jump, \{Victoria L.\}",

year = "2016",

month = jan,

day = "5",

doi = "10.18632/ONCOTARGET.5834",

language = "American English",

volume = "7",

journal = "Oncotarget",

number = "1",

}

TY - JOUR

T1 - The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.

AU - Stine, Jessica E.

AU - Guo, Hui

AU - Sheng, Xiugui

AU - Han, Xiaoyun

AU - Schointuch, Monica N.

AU - Gilliam, Timothy P.

AU - Gehrig, Paola A.

AU - Zhou, Chunxiao

AU - Bae-Jump, Victoria L.

PY - 2016/1/5

Y1 - 2016/1/5

UR - http://www.europepmc.org/articles/PMC4808044/

U2 - 10.18632/ONCOTARGET.5834

DO - 10.18632/ONCOTARGET.5834

M3 - Article

VL - 7

JO - Oncotarget

JF - Oncotarget

IS - 1

ER -

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.

Disciplines

Access to Document

Other files and links

Cite this